Euglycemic diabetic ketoacidosis induced by SGLT2 inhibitors: possible mechanism and contributing factors - Ogawa - 2016 - Journal of Diabetes Investigation - Wiley Online Library
American Association of Clinical Endocrinologists and American College of Endocrinology Position Statement on the Association of SGLT-2 Inhibitors and Diabetic Ketoacidosis - Endocrine Practice
PDF] Euglycemic Diabetic Ketoacidosis: A Predictable, Detectable, and Preventable Safety Concern With SGLT2 Inhibitors | Semantic Scholar
Management of Euglycemic Diabetic Ketoacidosis
EUGLYCEMIC DKA FROM AN SGLT2 INHIBITOR IN A HEART TRANSPLANT PATIENT | Journal of the American College of Cardiology
SGLT2 inhibitors – moving on with the evidence - DiabetesontheNet
Cureus | Euglycemic Diabetic Ketoacidosis and Sodium-Glucose Cotransporter-2 Inhibitors: A Focused Review of Pathophysiology, Risk Factors, and Triggers
Euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter-2 inhibitor use: a case report and review of the literature | International Journal of Emergency Medicine | Full Text
Euglycemic diabetic ketoacidosis with canagliflozin | The College of Family Physicians of Canada
Euglycemic diabetic ketoacidosis: A missed diagnosis
PDF] The DKA that wasn't: a case of euglycemic diabetic ketoacidosis due to empagliflozin | Semantic Scholar
Two-hit hypothesis for the effect of SGLT2 inhibitors to promote... | Download Scientific Diagram
Euglycemic DKA: It's not a Myth - REBEL EM - Emergency Medicine Blog
Possible association between diabetic ketoacidosis and use of sodium-glucose co-transporter 2 inhibitor in a 17-year-old youth with type 2 diabetes | CMAJ